203 results on '"Goka, Bamenla Q."'
Search Results
2. Neonatal near-misses in Ghana: a prospective, observational, multi-center study
3. Performance of a histidine rich protein-2 based (First Response) and a p-lactate dehydrogenase-based (Optimal) rapid diagnostic test for diagnosis of malaria in patients with pediatric sickle cell disease
4. Performance of a Histidine Rich Protein-2 Based (First Response) and a p-Lactate Dehydrogenase-based (Optimal) Rapid Diagnostic Test for Diagnosis of Malaria in Patients With Pediatric Sickle Cell Disease
5. Plasma Concentrations of Soluble Urokinase-Type Plasminogen Activator Receptor Are Increased in Patients with Malaria and Are Associated with a Poor Clinical or a Fatal Outcome
6. Performance of a Histidine Rich Protein-2 Based (First Response) and a p-Lactate Dehydrogenase-based (Optimal) Rapid Diagnostic Test for Diagnosis of Malaria in Patients With Pediatric Sickle Cell Disease.
7. HIV virological non-suppression and its associated factors amongst children on antiretroviral therapy at a major paediatric treatment centre in Southern Ghana: a cross-sectional study
8. Enrolment of children in clinical research:Understanding Ghanaian caregivers’ perspectives on consent/assent procedures, and their attitudes towards storage of biological samples for future use
9. Plasma folatelLevels in acutely ill and steady state pediatric sickle cell disease patients in Ghana
10. Enrolment of children in clinical research: Understanding Ghanaian caregivers’ perspectives on consent/assent procedures, and their attitudes towards storage of biological samples for future use
11. Reticulocyte count changes in paediatric patients with uncomplicated malaria treated with artemisinin combination therapy
12. Neonatal Near-Misses in Ghana: A Prospective, Observational, Multi-Center Study
13. Artemether–lumefantrine: an oral antimalarial for uncomplicated malaria in children
14. Factors Contributing to the Development of Anaemia in Plasmodium falciparum Malaria: What about Drug-Resistant Parasites?
15. Pretreatment Blood Concentrations of Chloroquine in Patients with Malaria Infection: Relation to Response to Treatment
16. Population pharmacokinetic estimates suggest elevated clearance and distribution volume of desethylamodiaquine in pediatric patients with sickle Cell disease treated with artesunate-amodiaquine
17. Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine
18. Enrolment of children in clinical research: Understanding Ghanaian caregivers' perspectives on consent/assent procedures, and their attitudes towards storage of biological samples for future use.
19. Population Pharmacokinetic Estimates Suggest Elevated Clearance and Distribution Volume of Desethylamodiaquine in Pediatric Patients with Sickle Cell Disease Treated with Artesunate-Amodiaquine
20. Elevated levels of nitric oxide and low levels of haptoglobin are associated with severe malarial anaemia in African children
21. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up
22. Complement activation in Ghanaian children with severe Plasmodium falciparum malaria
23. Plasma Folate Levels in Acutely Ill and Steady State Pediatric Sickle Cell Disease Patients in Ghana.
24. Bone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemia
25. Pneumonia in Ghana—a need to raise the profile
26. A STAT6 Intronic Single-Nucleotide Polymorphism is Associated with Clinical Malaria in Ghanaian Children
27. A STAT6 Intronic Single-Nucleotide Polymorphism is Associated with Clinical Malaria in Ghanaian Children
28. Polymorphisms in the Haem Oxygenase-1 promoter are not associated with severity of Plasmodium falciparum malaria in Ghanaian children
29. Polymorphisms in the Haem Oxygenase-1 promoter are not associated with severity of Plasmodium falciparum malaria in Ghanaian children
30. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria
31. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria
32. Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in Southern Ghana
33. Reversible audiometric threshold changes in children with uncomplicated malaria
34. High Plasma Levels of Soluble Intercellular Adhesion Molecule (ICAM)-1 Are Associated with Cerebral Malaria
35. Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in Southern Ghana
36. Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine
37. Levels of soluble CD163 and severity of malaria in children in Ghana.
38. Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria
39. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up
40. Reversible Audiometric Threshold Changes in Children with Uncomplicated Malaria
41. Complement activation in Ghanaian children with severe Plasmodium falciparum malaria
42. Neurotoxicity of artemisinin derivatives
43. Are currently deployed artemisinins neurotoxic?
44. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome
45. Bone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemia
46. Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens
47. Comparison of chloroquine with Quinimax(R) in the treatment of cerebral malaria in Ghanaian children
48. Severe malaria in west African children
49. Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes
50. Acute P. falciparum malaria induces a loss of CD28- T IFN-¿ producing cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.